Dr. Vuong Trieu, CEO of Oncotelic Therapeutics Inc. (OTC: OTLC), was recently a guest on Benzinga All Access.
Discover how AI is revolutionizing RNA drug development in a new article published in Engineering. Learn about the potential ...
UB researcher Murali Ramanathan has used artificial intelligence (AI) since its nascent days while exploring possible treatments for multiple sclerosis (MS) and Alzheimer’s disease. Today, Ramanathan, ...
Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic ...
Hosted on MSN
The first AI-generated drug enters clinical trials
The world of medicine has taken a significant leap forward with the first AI-generated drug entering clinical trials. This breakthrough has the potential to revolutionize drug discovery, transforming ...
Hangzhou-based biotech start-up MindRank has progressed to Phase 3 clinical trials for its weight-loss drug, making it ...
Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets ...
The rapid advancement of artificial intelligence (AI) is transforming the field of structural biology. In May 2024, DeepMind and Isomorphic Labs launched AlphaFold 3 (AF3), a revolutionary AI system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback